UX Designer & Prototyper

Developing a frictionless robotic surgical system that provides medical professionals confidence in navigating the future of soft tissue robotic surgery.

Overview

I had the amazing opportunity to spend the last 3 years with J&J at the Santa Clara R&D facility. As a UX Designer & Prototyper for the OTTAVA™ robotic surgical system, I worked on everything from User research/testing, Design Systems, Micro-interactions, and Advanced multi-device prototyping. Working alongside a team of talented designers, researchers, engineers, PMs, human factors specialists, and surgeons throughout this experience helping cultivate my skills and knowledge as a UX Designer.

The OTTAVA™ System is designed to transform the surgical experience with innovative architecture, clinically relevant features, and trusted Ethicon instrumentation. It is the world's first table-integrated soft-tissue robotic surgery system.

Role

UX Designer & Prototyper

Skills

Product Design

Advanced Prototyping

Design Systems

Usability Testing

Team

OTTAVA™ HFXD Team

UX/Industrial Design

Human Factors Engineers

Clinical Engineers

GUI Developers

In-House Surgeons

Timeline

Jun 2024 - July 2026

Please contact me for more information about this project experience!

* Project Under NDA *

Johnson & Johnson receives FDA market authorization in the U.S. for its OTTAVA™ robotic surgical system.

How might the OTTAVA™ System reimagine the future of surgical experiences for surgeons, operating room staff, and patients?

— Key Learnings

Developed MVP's, Design System, Advanced Prototypes, and conducted User Interviews/Testing alongside a cross-functional team of stakeholders.

Creating impact through...

— Contextualizing

Collaboration with stakeholders on aligning business goals with user needs, and contextualizing through working with equipment and workflows.

A huge shoutout to the wonderful folks at J&J for taking good care of me during my time on the team!

— Company Updates/Releases

Nov. 7, 2023 – New Brunswick, New Jersey – Johnson & Johnson MedTech* today announced plans to submit the OTTAVA robotic surgical system for an investigational device exemption (IDE) application to the U.S. Food & Drug Administration (FDA) in the second half of 2024 to initiate clinical trials. Drawing on Johnson & Johnson MedTech’s more than 135-year legacy of leadership in surgery, OTTAVA reimagines the surgical experience. The system is designed to create space in the operating room (OR), simplify complex workflows, enable flexibility for clinical approaches, and deliver the trusted performance of Ethicon** instrumentation.